These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 302119)

  • 21. A randomized comparative trial of adriamycin versus methotrexate in combination drug therapy.
    Bull JM; Tormey DC; Li SH; Carbone PP; Falkson G; Blom J; Perlin E; Simon R
    Cancer; 1978 May; 41(5):1649-57. PubMed ID: 348293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclophosphamide, adriamycin, methotrexate, and procarbazine (CAMP) treatment of non-oat cell bronchogenic carcinoma.
    Vogelzang NJ; Bonomi PD; Rossof AH; Wolter J
    Cancer Treat Rep; 1978 Oct; 62(10):1595-7. PubMed ID: 709563
    [No Abstract]   [Full Text] [Related]  

  • 23. Sequential combination chemotherapy of advanced head and neck carcinoma: re-evaluation of a highly effective regimen.
    Veronesi A; Barzan L; Magri MD; Tirelli U; Galligioni E; Trovò MG; Tumolo S; Comoretto R; Grigoletto E
    Strahlentherapie; 1981 Apr; 157(4):277-9. PubMed ID: 6166105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of chemotherapy in lung cancer (controlled trials).
    Shnider BI
    Med Ann Dist Columbia; 1971 Aug; 40(8):489-95. PubMed ID: 5001653
    [No Abstract]   [Full Text] [Related]  

  • 25. Combined modality therapy for stage IIIMO non-oat cell bronchogenic carcinoma.
    Bitran JD; Desser RK; DeMeester T; Shapiro CM; Billings A; Rubenstein L; Evans R; Colman M; Rao CY; Griem M; Golomb HM
    Cancer Treat Rep; 1978 Mar; 62(3):327-32. PubMed ID: 348305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemotherapeutic studies in bronchogenic carcinoma by the Austrian study group.
    Karrer K; Pridun N; Zwintz E
    Cancer Chemother Rep 3; 1973 Mar; 4(2):207-13. PubMed ID: 4729324
    [No Abstract]   [Full Text] [Related]  

  • 27. [Chemotherapy schedule for the management of metastasizing gastric cancer. Methotrexate, adriamycin and 5-fluorouracil].
    Klein HO; Wickramanayake PD; Dieterle F; Mohr R; Oerkermann H; Brock J; Beyer D; Gross R
    Dtsch Med Wochenschr; 1982 Nov; 107(45):1708-12. PubMed ID: 7140549
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-dose cyclophosphamide versus cyclophosphamide, methotrexate, 5-FU, and hydroxyurea (CMFH) in the treatment of stage III non-small cell bronchogenic carcinoma: a randomized trial.
    Pannuti F; Lelli G; Casadio M; Piana E; Di Marco AR
    Cancer Treat Rep; 1980; 64(10-11):1131-4. PubMed ID: 7459899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemo-immunotherapy for unresectable bronchogenic carcinoma.
    Sarna GP; Lowitz BB; Haskell CM; Dorey FJ; Cline MJ
    Cancer Treat Rep; 1978 May; 62(5):681-7. PubMed ID: 350397
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metastatic non-small cell bronchogenic carcinoma: a randomized trial of sequential vs combination chemotherapy.
    Hoffman PC; Newman SB; Golomb HM; Demeester TR; Blough RR; Sovik CA
    Eur J Cancer Clin Oncol; 1983 Jan; 19(1):33-8. PubMed ID: 6303793
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Small cell bronchogenic carcinoma. A prolonged remission following chemotherapy.
    Cohen MH
    JAMA; 1977 Jun; 237(23):2528. PubMed ID: 576972
    [No Abstract]   [Full Text] [Related]  

  • 32. [After care in bronchial carcinoma. Results of postoperative polychemotherapy].
    Karrer K; Pridun N; Denck H
    Fortschr Med; 1976 Mar; 94(7):379-85. PubMed ID: 184021
    [No Abstract]   [Full Text] [Related]  

  • 33. Relationship between myelosuppression and chemotherapeutic response in small cell bronchogenic carcinoma.
    Holoye PY
    Exp Hematol; 1985; 13 Suppl 16():72-9. PubMed ID: 2985416
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Remission rates, survival, and prognostic factors in combination chemotherapy for bronchogenic carcinoma.
    Alberto P
    Cancer Chemother Rep 3; 1973 Mar; 4(2):199-206. PubMed ID: 4729321
    [No Abstract]   [Full Text] [Related]  

  • 35. A combination of adriamycin, CCNU and hydroxyurea in the treatment of disseminated bronchogenic carcinoma.
    Alberto P; Barrelet L; Chapuis B; Garcia B
    Eur J Cancer (1965); 1975 Nov; 11(11):795-9. PubMed ID: 767111
    [No Abstract]   [Full Text] [Related]  

  • 36. Heparin anticoagulation as adjuvant to chemotherapy in carcinoma of the lung.
    Elias EG
    J Med; 1974; 5(1):114-32. PubMed ID: 4364885
    [No Abstract]   [Full Text] [Related]  

  • 37. [Prognostic factors in the chemotherapy of bronchial cancers].
    Alberto P
    Schweiz Med Wochenschr; 1974 Feb; 104(8):268-71. PubMed ID: 4360755
    [No Abstract]   [Full Text] [Related]  

  • 38. A pilot study of sequential combination chemotherapy with adriamycin and cyclophosphamide, and methotrexate, 5-fluorouracil and prednisolone in advanced breast cancer.
    Collis CH
    Br J Clin Pract; 1978 May; 32(5):139-44. PubMed ID: 666968
    [No Abstract]   [Full Text] [Related]  

  • 39. [Cancer chemotherapy of inoperable bronchial carcinomas (author's transl)].
    Rieche K
    Z Erkr Atmungsorgane; 1975 Feb; 142(2):140-8. PubMed ID: 179223
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination chemotherapy for non-small cell bronchogenic carcinoma with bleomycin, doxorubicin, methotrexate, and cis-dichlorodiammineplatinum(II) (BAMP).
    Vogl SE; Wollner D; Kaplan BH; Berenzweig M
    Cancer Treat Rep; 1980; 64(4-5):717-9. PubMed ID: 6159081
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.